Exploring the Impact of Controlled Ovarian Stimulation and Non-Invasive Oocyte Assessment in ART Treatments.

Autor: Sciorio, Romualdo¹ (AUTHOR) sciorioromualdo@hotmail.com, Cariati, Federica² (AUTHOR) cariati@ceinge.unina.it, Fleming, Steven³ (AUTHOR) blueyfleming@gmail.com, Alviggi, Carlo^4,5,6 (AUTHOR) carlo.alviggi@unina.it

Publikováno v: Life (2075-1729). Oct2023, Vol. 13 Issue 10, p1989. 17p.

Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study.

Autor: Haas, Jigal^1,2 (AUTHOR), Zilberberg, Eran^1,2 (AUTHOR), Nahum, Ravit^1,2 (AUTHOR), Mor Sason, Aya^1,2 (AUTHOR), Hourvitz, Ariel^1,2 (AUTHOR), Gat, Itai^1,2 (AUTHOR), Orvieto, Raoul^1,2,3 (AUTHOR) raoul.orvieto@sheba.health.gov.il

Publikováno v: Gynecological Endocrinology. Jul2019, Vol. 35 Issue 7, p628-630. 3p.

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With "Genuine" Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF.

Autor: Orvieto, Raoul, Kirshenbaum, Michal, Galiano, Valentina, Elkan-Miller, Tal, Zilberberg, Eran, Haas, Jigal, Nahum, Ravit

Publikováno v: Frontiers in Endocrinology; 5/22/2020, Vol. 11, p1-5, 5p

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders

Autor: Salvatore Longobardi, W Chin, Joan C Schertz, Thomas D'Hooghe, D Rogoff, J Hubbard, Peter Humaidan

Publikováno v: Humaidan, P, Chin, W, Rogoff, D, D'Hooghe, T, Longobardi, S, Hubbard, J, Schertz, J & ESPART Study Investigators 2017, ' Efficacy and safety of follitropin alfa/lutropin alfa in ART : a randomized controlled trial in poor ovarian responders ', Human reproduction (Oxford, England), vol. 32, no. 3, pp. 544-555 . https://doi.org/10.1093/humrep/dew360
Human Reproduction (Oxford, England)
Humaidan, P, Chin, W, Rogoff, D, D'Hooghe, T, Longobardi, S, Hubbard, J & Schertz, J 2017, ' Efficacy and safety of follitropin alfa/lutropin alfa in ART : a randomized controlled trial in poor ovarian responders ', Human reproduction (Oxford, England), vol. 32, no. 7, pp. 1537-1538 . https://doi.org/10.1093/humrep/dex208

STUDY QUESTION: How does the efficacy and safety of a fixed-ratio combination of recombinant human FSH plus recombinant human LH (follitropin alfa plus lutropin alfa; r-hFSH/r-hLH) compare with that of r-hFSH monotherapy for controlled ovarian stimul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2f13ebb66b30fbabbbaa192e58c5a8e
https://doi.org/10.1093/humrep/dex208